Condition
Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02378220Not ApplicableCompleted
Pharmacogenetic Testing Among Home Health Patients
NCT01778907Phase 4Completed
Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)
NCT02191358Completed
YouScript IMPACT Registry
NCT02428660Not ApplicableCompleted
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Showing all 4 trials